Evidence map›Paper›PMID 39581161›Full record

ArticleJournal of molecular and cellular cardiology2025

PERM1 regulates mitochondrial energetics through O-GlcNAcylation in the heart.

Karthi Sreedevi, Amina James, Sara Do, Shreya Yedla, Sumaita Arowa, Shin-Ichi Oka, Adam R Wende, Alexey V Zaitsev, Junco S Warren

Abstract read
In one paragraph

Article in Journal of molecular and cellular cardiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Karthi SreedeviFralin Biomedical Research Institute at Virginia Tech Carilion, Virginia Tech, Roanoke, VA, USA.
Amina JamesFralin Biomedical Research Institute at Virginia Tech Carilion, Virginia Tech, Roanoke, VA, USA.
Sara DoFralin Biomedical Research Institute at Virginia Tech Carilion, Virginia Tech, Roanoke, VA, USA.
Shreya YedlaFralin Biomedical Research Institute at Virginia Tech Carilion, Virginia Tech, Roanoke, VA, USA.
Sumaita ArowaFralin Biomedical Research Institute at Virginia Tech Carilion, Virginia Tech, Roanoke, VA, USA.
Shin-Ichi OkaDepartiment of Cell and Molecular Biology, Rutgers New Jersey Medical School, Newark, NJ, USA.
Adam R WendeDivision of Molecular and Cellular Pathology, Department of Pathology, University of Alabama at Birmingham, Birmingham, AL, USA.
Alexey V ZaitsevFralin Biomedical Research Institute at Virginia Tech Carilion, Virginia Tech, Roanoke, VA, USA.
Junco S WarrenFralin Biomedical Research Institute at Virginia Tech Carilion, Virginia Tech, Roanoke, VA, USA; Center for Vascular and Heart Research, Fralin Biomedical Research Institute, Virginia Tech, Roanoke, VA, USA; Department of Human Nutrition, Food and Exercise, Virginia Tech, Blacksburg, VA, USA. Electronic address: juncowarren@vtc.vt.edu.

Funding

Perm1 is a Novel Regulator of Cardiac Energetics and FunctionR01HL156667 · NHLBI · VIRGINIA POLYTECHNIC INST AND ST UNIV · PI DRAKOS, STAVROS GEORGE, WARREN, JUNKO SHIBAYAMA · 2021 to 2024
$2.0M
NHLBI NIH HHS R01 HL156667
6 · The paper itself

Abstract

PERM1 was initially identified as a new downstream target of PGC-1α and ERRs that regulates mitochondrial bioenergetics in skeletal muscle. Subsequently, we and other groups demonstrated that PERM1 is also a positive regulator of mitochondrial bioenergetics in the heart. However, the exact mechanisms of regulatory functions of PERM1 remain poorly understood. O-GlcNAcylation is a post-translational modification of proteins that are regulated by two enzymes: O-GlcNAc transferase (OGT) that adds O-GlcNAc to proteins; O-GlcNAcase (OGA) that removes O-GlcNAc from proteins. O-GlcNAcylation is a powerful signaling mechanism mediating cellular responses to stressors and nutrient availability, which, among other targets, may influence cardiac metabolism. We hypothesized that PERM1 regulates mitochondrial energetics in cardiomyocytes through modulation of O-GlcNAcylation. We found that overexpression of PERM1 decreased the total levels of O-GlcNAcylated proteins, concomitant with decreased OGT and increased OGA expression levels. Luciferase gene reporter assay showed that PERM1 significantly decreases the promoter activity of Ogt without changing the promoter activity of Oga. The downregulation of OGT by PERM1 overexpression was mediated through its interaction with E2F1, a known transcription repressor of Ogt. A deliberate increase of O-GlcNAcylation through Oga silencing in cardiomyocytes decreased the basal and maximal mitochondrial respiration and ATP production rates, all of which were completely restored by PERM1 overexpression. Furthermore, excessive O-GlcNAcylation caused by the loss of PERM1 led to the increase of O-GlcNAcylated PGC-1α, a master regulator of mitochondrial bioenergetics, concurrent with the dissociation of PGC-1α from PPARα, a well-known transcription factor that regulates fatty acid β-oxidation. We conclude that PERM1 positively regulates mitochondrial energetics, in part, via suppressing O-GlcNAcylation in cardiac myocytes.

Indexed as

Energy MetabolismMitochondria, HeartMyocytes, CardiacN-AcetylglucosaminyltransferasesAcetylglucosamineAcylationAnimalsbeta-N-AcetylhexosaminidasesGlycosylationHumansMiceMyocardiumPeroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alphaProtein Processing, Post-TranslationalAcetylglucosaminebeta-N-Acetylhexosaminidaseshexosaminidase CN-AcetylglucosaminyltransferasesO-GlcNAc transferasePeroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alphaCardiac metabolismE2F1Mitochondrial energeticsO-GlcNAcylationPERM1PGC-1α

Identifiers

PMID39581161
PMCPMC12646366

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.